title: Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction.
abstract: BACKGROUND
  Quantitative real-time polymerase chain reaction (Q-Rt-PCR) is a new tool in the detection and quantification of the BCR/abl fusion transcripts in chronic myelogenous leukemia (CML). This study investigates its specificity, sensitivity and potential clinical usefulness.
  
  
  METHODS
  Parallel analysis of Q-Rt-PCR and the conventional reverse transcription-mediated PCR (RT-PCR) were performed on 567 samples from 481 patients. Treatment response was monitored by Q-Rt-PCR at 6 and 12 months of 61 patients on STI-571 and 103 patients on interferon.
  
  
  RESULTS
  The concordance rate between Q-Rt-PCR and RT-PCR was 96.3% (546/567), with 341 positives and 205 negatives. The positive equivalents ranged from 2 x 10(-6) to 1.2 microg of K562 cell RNA. Karyotyping in 372 samples revealed excellent correlation with Q-Rt-PCR measurements (P < 0.001). Setting residual BCR/abl < 0.01 as an early goal of molecular response, we observed that STI-571 induced a better response than interferon: 49% (20 of 41 patients) versus 35% (15 of 62 patients) at 6 months (P = 0.025) and 52% (32 of 61 patients) versus 34% (35 of 103 patients) at 12 months (P = 0.01), respectively.
  
  
  CONCLUSIONS
  Q-Rt-PCR provides reliable measurements of BCR/abl fusion transcripts. It is potentially useful in assessing molecular residual disease after therapy.
authors.affiliation: Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston 77030, USA. mslee@mdanderson.org
authors.forename: W I
authors.initials: WI
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: A
authors.initials: A
authors.lastname: Glassman
authors.forename: M
authors.initials: M
authors.lastname: Talpaz
authors.forename: M S
authors.initials: MS
authors.lastname: Lee
mesh_terms: D001483:Base Sequence; D001853:Bone Marrow; D016022:Case-Control Studies; D046508:Culture Techniques; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D016313:Genes, abl / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*; D008297:Male; D008969:Molecular Sequence Data; D011336:Probability; D012016:Reference Values; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D014158:Transcription, Genetic
chemical_list: D016044:Fusion Proteins, bcr-abl